Hongchao Tang
158 Shangtang Road
Hangzhou, 310014, China
Hangzhou, 310014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A Single-Amino-Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome-Targeted Degradation of Membrane Proteins.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 06, 2026
Poria cocos-derived exosome-like nanoparticles ameliorate lymphedema by reprogramming fibroblast metabolism via enhanced TCA cycle flux.
Journal: Journal of nanobiotechnology
Published: December 24, 2025
UBE2K promotes breast cancer growth by ubiquitinating and degrading STUB1 to regulate the PKA/CREB1 signaling pathway, forming a feedback loop.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 03, 2025
Genipin, A Gut Microbiota-Derived Metabolite of Xihuang Pill, Suppresses Triple-Negative Breast Cancer Angiogenesis by Inhibiting HIF-1α/HSPG2 Axis.
Journal: Phytotherapy research : PTR
Published: October 16, 2025
Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy.
Journal: Journal of nanobiotechnology
Published: April 16, 2025
Integrative single-cell and bulk RNA sequencing of lactate metabolism identifies PDP-1 as a prognostic biomarker in breast cancer.
Journal: International journal of biological macromolecules
Published: April 13, 2025
Tumor-colonizing Pseudoalteromonas elyakovii metabolically reprograms the tumor microenvironment and promotes breast ductal carcinoma.
Journal: mBio
Published: April 07, 2025
Machine learning analysis of coagulation-related genes for breast cancer diagnosis and prognosis prediction.
Journal: Scientific reports
Published: November 08, 2024
Research progress in tumor angiogenesis and drug resistance in breast cancer.
Journal: Cancer biology & medicine
Published: June 28, 2024
Whole transcriptome sequencing indicated the Anti-tumor immunity of NLRP3 in breast cancer.
Journal: Genomics
Published: May 18, 2024
Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways.
Journal: Cancer cell international
Published: March 16, 2024
Last Updated: 09/26/2026